BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 32390875)

  • 1. Molecular Mechanism of Hippo-YAP1/TAZ Pathway in Heart Development, Disease, and Regeneration.
    Chen X; Li Y; Luo J; Hou N
    Front Physiol; 2020; 11():389. PubMed ID: 32390875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine.
    Nagashima S; Bao Y; Hata Y
    Curr Drug Targets; 2017; 18(4):447-454. PubMed ID: 26758663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt, RSPO and Hippo Signalling in the Intestine and Intestinal Stem Cells.
    Kriz V; Korinek V
    Genes (Basel); 2018 Jan; 9(1):. PubMed ID: 29316729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Yap1/Taz signaling in ischemic heart disease and dilated cardiomyopathy.
    Hou N; Wen Y; Yuan X; Xu H; Wang X; Li F; Ye B
    Exp Mol Pathol; 2017 Dec; 103(3):267-275. PubMed ID: 29154888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential influence of YAP1 and TAZ on differentiation of intestinal epithelial cell: A review.
    Fallah S; Beaulieu JF
    Anat Rec (Hoboken); 2023 May; 306(5):1054-1061. PubMed ID: 35648375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yes-associated protein 1 is required for proliferation and function of bovine granulosa cells in vitro†.
    Plewes MR; Hou X; Zhang P; Liang A; Hua G; Wood JR; Cupp AS; Lv X; Wang C; Davis JS
    Biol Reprod; 2019 Nov; 101(5):1001-1017. PubMed ID: 31350850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparative Analysis of Hippo Signaling Pathway Components during Murine and Bovine Early Mammalian Embryogenesis.
    Sharma J; Antenos M; Madan P
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33669396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.
    Kaneda A; Seike T; Danjo T; Nakajima T; Otsubo N; Yamaguchi D; Tsuji Y; Hamaguchi K; Yasunaga M; Nishiya Y; Suzuki M; Saito JI; Yatsunami R; Nakamura S; Sekido Y; Mori K
    Am J Cancer Res; 2020; 10(12):4399-4415. PubMed ID: 33415007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yap1/Taz are essential for the liver development in zebrafish.
    Yi X; Yu J; Ma C; Li L; Luo L; Li H; Ruan H; Huang H
    Biochem Biophys Res Commun; 2018 Sep; 503(1):131-137. PubMed ID: 29859190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Hippo-YAP1/TAZ pathway and its crosstalk in cardiac biology.
    Chen X; Yuan W; Li Y; Luo J; Hou N
    Int J Biol Sci; 2020; 16(13):2454-2463. PubMed ID: 32760212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications.
    Sun T; Chi JT
    Genes Dis; 2021 May; 8(3):241-249. PubMed ID: 33997171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alantolactone is a natural product that potently inhibits YAP1/TAZ through promotion of reactive oxygen species accumulation.
    Nakatani K; Maehama T; Nishio M; Otani J; Yamaguchi K; Fukumoto M; Hikasa H; Hagiwara S; Nishina H; Mak TW; Honma T; Kondoh Y; Osada H; Yoshida M; Suzuki A
    Cancer Sci; 2021 Oct; 112(10):4303-4316. PubMed ID: 34289205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanotransduction and Cytoskeleton Remodeling Shaping YAP1 in Gastric Tumorigenesis.
    Zhang J; Zhou Y; Tang PMK; Cheng ASL; Yu J; To KF; Kang W
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting YAP1/TAZ in nonsmall-cell lung carcinoma: From molecular mechanisms to precision medicine.
    Mui CW; Chan WN; Chen B; Cheung AH; Yu J; Lo KW; Ke H; Kang W; To KF
    Int J Cancer; 2023 Feb; 152(4):558-571. PubMed ID: 35983734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated microRNA let-7a accelerates apoptosis and inhibits proliferation in uterine junctional zone smooth muscle cells in adenomyosis under conditions of a normal activated hippo-YAP1 axis.
    Huang JH; Duan H; Wang S; Wang YY; Lv CX
    Reprod Biol Endocrinol; 2021 Jun; 19(1):81. PubMed ID: 34082774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer.
    García P; Rosa L; Vargas S; Weber H; Espinoza JA; Suárez F; Romero-Calvo I; Elgueta N; Rivera V; Nervi B; Obreque J; Leal P; Viñuela E; Aguayo G; Muñiz S; Sagredo A; Roa JC; Bizama C
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32218280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.
    Huang J; Yang J; Zhang Y; Lu D; Dai Y
    Exp Cell Res; 2023 Jun; 427(1):113585. PubMed ID: 37030332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP1 is involved in replenishment of granule cell precursors following injury to the neonatal cerebellum.
    Yang Z; Joyner AL
    Dev Biol; 2019 Nov; 455(2):458-472. PubMed ID: 31376393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippo pathway effectors YAP/TAZ as novel determinants of ferroptosis.
    Yang WH; Chi JT
    Mol Cell Oncol; 2020; 7(1):1699375. PubMed ID: 31993503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.